candesartan cilexetil hydrochlorothiazide
candesartan cilexetil hydrochlorothiazide · CANDESARTAN CILEXETIL 32 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet · AstraZeneca AB
NDC 17228-0322-09 · 30000 TABLET in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of candesartan cilexetil hydrochlorothiazide (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| AstraZeneca AB | CANDESARTAN CILEXETIL 16 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca AB | CANDESARTAN CILEXETIL 32 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| AstraZeneca AB | CANDESARTAN CILEXETIL 32 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "candesartan cilexetil hydrochlorothiazide — NDC 17228-0322-09," retrieved September 3, 2026, https://drugdashboards.com/drug/17228032209.
Free to cite with attribution — see how the data is put together.